The election committee in Statoil ASA (OSE: STL, NYSE: STO) has proposed to the corporate assembly that Ingrid Wiik and Lars Thunell be appointed as new members of the board of directors. Election to the board will be on the agenda at the corporate assembly's meeting on 22 June.
Ingrid Wiik (60) is currently president and CEO of Alpharma in New York. Since 1983 she has held various managerial posts in Apothekernes Laboratorium/Alpharma, and has been CEO in the USA since 2000. Ms Wiik is a director of Coloplast in Denmark and Norske Skog in Norway.
Lars Thunell (56) is chief executive of SE-Banken, Stockholm. He was deputy managing director of ABB before becoming deputy chief executive of Nordbanken, chief executive of Securum and chief executive of Trygg-Hansa until its merger with SE-Banken. Mr Thunell is a director of Akzo Nobel (Sweden), the Swedish Bankers' Association and B-business partners (Sweden).
Eli Sætersmoen has notified the election committee that she wishes to withdraw from the board. The committee will propose to the corporate assembly that the board be expanded to include one additional member.
"It is important that Statoil's board has the experience and competence appropriate to the challenges that the group faces in the time ahead," says Anne Kathrine Slungård, chair of the election committee. "Ingrid Wiik and Lars Thunell both possess broad industrial and international experience which are elements key to Statoil's further development. The election committee is very pleased that Ms Wiik and Mr Thunell are willing to join Statoil's board of directors."
Contact person:
Anne Kathrine Slungård, chair of the election committee, tel +47 48 24 88 75.